Using RNAseq data from R4−/− MEFs and targeted approaches in our mouse samples, we posited β-catenin upregulation as the mechanism for memory rescue in the AD mouse model and put forward RHBDL4 as a novel negative regulator of β-catenin (Fig. 7). This evidence concerns the gene CD1A and Alzheimer disease.